Evidence map›Paper›PMID 24844383›Full record

ArticlePloS one2014

Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.

Tereza Martinu, Christine V Kinnier, Jesse Sun, Francine L Kelly, Margaret E Nelson, Stavros Garantziotis, W Michael Foster, Scott M Palmer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Tereza MartinuDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Christine V KinnierDepartment of General Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Jesse SunSchool of medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Francine L KellyDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Margaret E NelsonDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Stavros GarantziotisRespiratory Biology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States of America.
W Michael FosterDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Scott M PalmerDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke Medical Center · USMassachusetts General Hospital · USNational Institute of Environmental Health Sciences · USUniversity of North Carolina at Chapel Hill · US

Funding

The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue InjuryZIAES102605 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI GARANTZIOTIS, STAVROS · 2009 to 2025
$22.6M
MATRIX REGULATION OF FIBROPROLIFERATIVE LUNG DISEASEP50HL084917 · NHLBI · DUKE UNIVERSITY · PI KRAFT, MONICA · 2006 to 2010
$13.2M
Duke CTSIKL2RR024127 · NCRR · DUKE UNIVERSITY · PI CALIFF, ROBERT M · 2006 to 2011
$3.9M
Genetic Regulation of Lung Transplant OutcomesK24HL091140 · NHLBI · DUKE UNIVERSITY · PI PALMER, SCOTT M · 2008 to 2012
$712k
NCRR NIH HHS RR024 127-03NHLBI NIH HHS K24 HL091140NHLBI NIH HHS NIH 1 K24HL91140-01A2NHLBI NIH HHS P50 HL084917PHS HHS NIH/NHLBI 1P50-HL084917-01
6 · The paper itself

Abstract

backgroundPulmonary GVHD (pGVHD) is an important complication of hematopoietic cell transplant (HCT) and is thought to be a consequence of the HCT conditioning regimen, allogeneic donor cells, and posttransplant lung exposures. We have previously demonstrated that serial inhaled lipopolysaccharide (LPS) exposures potentiate the development of pGVHD after murine allogeneic HCT. In the current study we hypothesized that allogeneic lymphocytes and environmental exposures alone, in the absence of a pre-conditioning regimen, would cause features of pGVHD and would lead to a different T cell expansion pattern compared to syngeneic cells.

methodsRecipient Rag1-/- mice received a transfer of allogeneic (Allo) or syngeneic (Syn) spleen cells. After 1 week of immune reconstitution, mice received 5 daily inhaled LPS exposures and were sacrificed 72 hours after the last LPS exposure. Lung physiology, histology, and protein levels in bronchoalveolar lavage (BAL) were assessed. Lung cells were analyzed by flow cytometry.

resultsBoth Allo and Syn mice that undergo LPS exposures (AlloLPS and SynLPS) have prominent lymphocytic inflammation in their lungs, resembling pGVHD pathology, not seen in LPS-unexposed or non-transplanted controls. Compared to SynLPS, however, AlloLPS have significantly increased levels of BAL protein and enhancement of airway hyperreactivity, consistent with more severe lung injury. This injury in AlloLPS mice is associated with an increase in CD8 T cells and effector CD4 T cells, as well as a decrease in regulatory to effector CD4 T cell ratio. Additionally, cytokine analysis is consistent with a preferential Th1 differentiation and upregulation of pulmonary CCL5 and granzyme B.

conclusionsAllogeneic lymphocyte transfer into lymphocyte-deficient mice, followed by LPS exposures, causes features of pGVHD and lung injury in the absence of a pre-conditioning HCT regimen. This lung disease associated with an expansion of allogeneic effector T cells provides a novel model to dissect mechanisms of pGVHD independent of conditioning.

Indexed as

Adoptive TransferAdministration, InhalationAnimalsChemokine CCL5Disease Models, AnimalGraft vs Host DiseaseGranzymesHematopoietic Stem Cell TransplantationImmunophenotypingInterferon-gammaLipopolysaccharidesLung InjuryMaleMiceMice, KnockoutMyeloid CellsChemokine CCL5GranzymesInterferon-gammaLipopolysaccharides

Identifiers

PMID24844383
PMCPMC4028236
OpenAlexW1971892025

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.